Accessibility Menu
 
Universe Pharmaceuticals Inc logo

Universe Pharmaceuticals Inc

(NASDAQ) UPC

Current Price$2.70
Market Cap$1.55M
Since IPO (2021)-100%
5 Year-100%
1 Year-44%
1 Month-16%

Universe Pharmaceuticals Inc Financials at a Glance

Market Cap

$1.55M

Revenue (TTM)

$40.88M

Net Income (TTM)

$12.40M

EPS (TTM)

$-10.13

P/E Ratio

-0.27

Dividend

$0.00

Beta (Volatility)

0.06 (Low)

Price

$2.70

Volume

0

Open

$2.70

Previous Close

$2.70

Daily Range

$2.70 - $2.70

52-Week Range

$2.00 - $11.00

UPC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Universe Pharmaceuticals Inc

Industry

Pharmaceuticals

Employees

216

CEO

Gang Lai

Headquarters

Ji'An, 343100, CN

UPC Financials

Key Financial Metrics (TTM)

Gross Margin

35%

Operating Margin

-16%

Net Income Margin

-21%

Return on Equity

-7%

Return on Capital

-5%

Return on Assets

-5%

Earnings Yield

-3.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.55M

Shares Outstanding

563.30K

Volume

0

Avg. Volume

8.69K

Financials (TTM)

Gross Profit

$6.30M

Operating Income

$2.92M

EBITDA

$2.92M

Operating Cash Flow

$5.05M

Capital Expenditure

$347.19K

Free Cash Flow

$5.40M

Cash & ST Invst.

$33.59M

Total Debt

$9.26M

Universe Pharmaceuticals Inc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$8.71M

-37.1%

Gross Profit

$3.14M

-22.8%

Gross Margin

36.03%

N/A

Market Cap

$1.55M

N/A

Market Cap/Employee

$6.91K

N/A

Employees

225

N/A

Net Income

$387.30K

+92.9%

EBITDA

$36.21K

+99.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$24.34M

+86.9%

Accounts Receivable

$13.19M

+22.9%

Inventory

$2.19M

-34.4%

Long Term Debt

$0.00

N/A

Short Term Debt

$9.26M

+68.8%

Return on Assets

-5.30%

N/A

Return on Invested Capital

-5.19%

N/A

Free Cash Flow

$7.78M

-111.3%

Operating Cash Flow

$7.61M

-109.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NCELNewcelX Ltd.
$3.21-6.41%
TIVCTivic Health Systems, Inc.
$0.93-3.82%
BJDXBluejay Diagnostics, Inc.
$1.67-4.30%
SHPHShuttle Pharmaceuticals Holdings, Inc.
$0.67+4.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.06-0.10%
POETPoet Technologies
$15.97-0.22%
INTCIntel
$108.77-0.06%
NOKNokia
$13.95-0.04%

Questions About UPC

What is the current price of Universe Pharmaceuticals Inc?

Universe Pharmaceuticals Inc is trading at $2.70 per share.

What is the 52-week range for Universe Pharmaceuticals Inc?

Over the past 52 weeks, Universe Pharmaceuticals Inc has traded between $2.00 and $11.00.

How much debt does Universe Pharmaceuticals Inc have?

As of the most recent reporting period, Universe Pharmaceuticals Inc reported total debt of $9.26M.

How much cash does Universe Pharmaceuticals Inc have on hand?

Universe Pharmaceuticals Inc reported $33.59M in cash and cash equivalents in its most recent financial results.

What is Universe Pharmaceuticals Inc’s dividend yield?

Universe Pharmaceuticals Inc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.